An integrated centrifugal microfluidic CRISPR-based diagnostics platform for multiplexed point-of-care testing of respiratory pathogens
Biosensors and Bioelectronics · 2026-11 · 312 · 119083
DOI: 10.1016/j.bios.2026.119083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026-11. Verfasst von Lingyun Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Bioinformatics Center of AMMS, Beijing, 100850, PR China. Hauptthemen laut MEDLINE: Biosensing Techniques, Point-of-Care Testing, CRISPR-Cas Systems, Respiratory Tract Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Nova Program.
Abstract (Originalsprache)
Rapid, accurate, and multiplexed point-of-care testing (POCT) of respiratory pathogens is critical for clinical triage and infection control. However, existing platforms frequently necessitate trade-offs between sensitivity, throughput, and operational complexity. To address this, we developed the iCARD (integrated Centrifugal Assay on a Rotating Disc) platform, a streamlined microfluidic molecular diagnostic system based on single-step CRISPR kinetics and centrifugal microfluidics. Comprising a polymethyl methacrylate disc pre-loaded with lyophilized CRISPR/Cas13a reagents and a self-developed portable fluorescence analyzer, the platform enables automated multiplexed detection following sample loading. Furthermore, a novel resin-based pretreatment method was engineered to efficiently purify and concentrate nucleic acids from throat swabs. The iCARD system facilitates the parallel screening of six respiratory pathogens across four independent samples within 40 min. Analytical validation confirmed single-copy sensitivity (limit of detection: 0.25-1.0 copies/μL) without cross-reactivity. Clinical validation using 94 retrospective patient throat swabs demonstrated exceptional diagnostic accuracy, achieving a sensitivity of 95.5% (64/67; 95% CI: 87.64%-98.47%) and a specificity of 100.0% (27/27; 95% CI: 87.51%-100.00%). These findings demonstrate that the iCARD platform serves as a robust, high-throughput, and accurate diagnostic tool for decentralized molecular screening and epidemiological surveillance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Bioinformatics Center of AMMS, Beijing, 100850, PR China.
- Department of Laboratory Medicine, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, Shanghai, 200127, PR China.
- Anhui Province Key Laboratory of Respiratory Tumor and Infectious Disease, Molecular Diagnosis Center, Department of Pulmonary Critical Care Medicine, The First Affiliated Hospital of Bengbu Medical University, Bengbu,…
- Department of Laboratory Medicine, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, Shanghai, 200127, PR China. Electronic address: rjlimin@shsmu.edu.cn.
- Bioinformatics Center of AMMS, Beijing, 100850, PR China. Electronic address: sqwang@bmi.ac.cn.
- Bioinformatics Center of AMMS, Beijing, 100850, PR China. Electronic address: rongzhen0525@163.com.
Förderung
- National Natural Science Foundation of China
- Beijing Nova Program
Zitieren
APA
Li, L., Wei, H., Wei, M., Yang, X., Wang, T., Min, S., Wang, Y., Wang, X., Li, M., Wang, S., & Rong, Z. (2026). An integrated centrifugal microfluidic CRISPR-based diagnostics platform for multiplexed point-of-care testing of respiratory pathogens. Biosensors and Bioelectronics, 312, 119083. https://doi.org/10.1016/j.bios.2026.119083
Vancouver
Li L, Wei H, Wei M, Yang X, Wang T, Min S, et al. An integrated centrifugal microfluidic CRISPR-based diagnostics platform for multiplexed point-of-care testing of respiratory pathogens. Biosensors and Bioelectronics. 2026;312:119083. doi:10.1016/j.bios.2026.119083
BibTeX
@article{Li2026,
author = {Li, Lingyun and Wei, Hongjuan and Wei, Muyun and Yang, Xingsheng and Wang, Tianci and Min, Shengping and Wang, Yunxiang and Wang, Xiaojing and Li, Min and Wang, Shengqi and Rong, Zhen},
title = {An integrated centrifugal microfluidic CRISPR-based diagnostics platform for multiplexed point-of-care testing of respiratory pathogens},
journal = {Biosensors and Bioelectronics},
year = {2026},
volume = {312},
pages = {119083},
doi = {10.1016/j.bios.2026.119083}
}
EUVIMED